
IndraLab
Statements
reach
"Similarly to how ACE2 receptor inhibitors reduced SARS-CoV-1-induced acute respiratory distress syndrome (ARDS) [17], it seems that efforts to develop ACE2 receptor inhibitors (also known as ACE2 blockers such as enalapril, lisinopril, captopril, perindopril [18], [19]) for SARS-CoV-2 may be beneficial (Fig. 1
A)."
| PMC
reach
"In an animal model, the ACEI enalapril attenuated the downregulation of cardiac ACE2 after myocardial infarction.6465There is a clear benefit of ACEI and ARB in reducing thrombotic effects in hypertensive patients.6667Protection against severe lung damage could also be achieved by administering recombinant ACE2."